We have read “Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease” by Lindahl and colleagues with great interest, and congratulate the authors for their accurate analysis of this large population of patients with myocardial infarction with nonobstructive coronary arteries (MINOCA).¹

They retrospectively selected patients with MINOCA from the SWEDEHEART registry (the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies) thus obtaining a prevalence of 8.0%. For the first time, they clearly demonstrated an improvement in the prognosis of this population over …

我们非常感兴趣地阅读了Lindahl及其同事的“非阻塞性冠状动脉疾病的心肌梗死患者的二级预防和长期结果的药物治疗”，并祝贺作者对这一大量心肌梗死患者的准确分析表示祝贺。非阻塞性冠状动脉（MINOCA）。^1个

他们从SWEDEHEART注册中心（根据推荐疗法评估的瑞典基于证据的心脏病增强和发展网络系统）中回顾性选择了MINOCA患者，因此患病率为8.0％。首次，他们清楚地证明了该人群的预后比……有所改善。